NCT01995838 - A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia | Biotech Hunter

Enrollment

291

Participants

Timeline

Start Date

November 13, 2013

Primary Completion Date

April 29, 2014

Study Completion Date

April 29, 2014

Conditions

Chronic InsomniaAdultsElderly

Interventions

DRUG

E2006

E2006 1 mg, 2.5 mg, 5 mg, 10 mg, 15 mg, or 25 mg, in tablet form, taken orally, 30 minutes prior to bedtime, each night for 15 consecutive nights

DRUG

Placebo

E2006-matched placebo in tablet form, taken orally, 30 minutes prior to bedtime, each night for 15 consecutive nights

Trial Locations (29)

10019

New York

19118

Philadelphia

21061

Glen Burnie

22182

Vienna

27612

Raleigh

30342

Atlanta

33009

Hallandale

33024

Hollywood

33143

South Miami

33511

Brandon

45212

Cincinnati

45255

Cincinnati

60634

Chicago

60637

Chicago

66212

Overland Park

75230

Dallas

78731

Austin

78744

Austin

80907

Colorado Springs

80909

Colorado Springs

85006

Phoenix

85306

Glendale

89104

Las Vegas

91360

Thousand Oaks

92054

Oceanside

92103

San Diego

92123

San Diego

92708

Fountain Valley

29201-2953

Columbia

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY